Cannabis Products Global Market Report 2022 provides strategists, marketers and senior management with the critical information they need to assess the global cannabis products market.
The report focuses on the cannabis products market which is experiencing strong growth. The report gives a guide to the cannabis products market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic
Where is the largest and fastest growing market for the cannabis products? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cannabis Products Market Global Report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
1) By Product Type: Flower; Concentrates; Others
2) By Usage: Medical; Recreational
3) By Compound: THC-Dominant; CBD-Dominant; Balanced THC & CBD
4) By Route Of Administration: Oral Solutions And Capsules; Smoking; Vaporizers; Topicals; Others
Companies Mentioned: Canopy Growth Corporation; Aphria Inc.; Aurora Cannabis; Cara Therapeutics; GW Pharmaceuticals PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
The report focuses on the cannabis products market which is experiencing strong growth. The report gives a guide to the cannabis products market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
- Create regional and country strategies on the basis of local data and analysis
- Identify growth segments for investment
- Outperform competitors using forecast data and the drivers and trends shaping the market
- Understand customers based on the latest market research findings
- Benchmark performance against key competitors
- Utilize the relationships between key data sets for superior strategizing
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:
Where is the largest and fastest growing market for the cannabis products? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cannabis Products Market Global Report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The Market Characteristics section of the report defines and explains the market
- The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery
- Market segmentations break down market into sub markets
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers
Scope
Markets Covered:
1) By Product Type: Flower; Concentrates; Others
2) By Usage: Medical; Recreational
3) By Compound: THC-Dominant; CBD-Dominant; Balanced THC & CBD
4) By Route Of Administration: Oral Solutions And Capsules; Smoking; Vaporizers; Topicals; Others
Companies Mentioned: Canopy Growth Corporation; Aphria Inc.; Aurora Cannabis; Cara Therapeutics; GW Pharmaceuticals PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Frequently Asked Questions about the Global Cannabis Products Market
What is the estimated value of the Global Cannabis Products Market?
What is the growth rate of the Global Cannabis Products Market?
What is the forecasted size of the Global Cannabis Products Market?
Who are the key companies in the Global Cannabis Products Market?
Table of Contents
1. Executive Summary2. Cannabis Products Market Characteristics3. Cannabis Products Market Trends And Strategies4. Impact Of COVID-19 On Cannabis Products28. Key Mergers And Acquisitions In The Cannabis Products Market29. Cannabis Products Market Future Outlook and Potential Analysis
5. Cannabis Products Market Size And Growth
6. Cannabis Products Market Segmentation
7. Cannabis Products Market Regional And Country Analysis
8. Asia-Pacific Cannabis Products Market
9. China Cannabis Products Market
10. India Cannabis Products Market
11. Japan Cannabis Products Market
12. Australia Cannabis Products Market
13. Indonesia Cannabis Products Market
14. South Korea Cannabis Products Market
15. Western Europe Cannabis Products Market
16. UK Cannabis Products Market
17. Germany Cannabis Products Market
18. France Cannabis Products Market
19. Eastern Europe Cannabis Products Market
20. Russia Cannabis Products Market
21. North America Cannabis Products Market
22. USA Cannabis Products Market
23. South America Cannabis Products Market
24. Brazil Cannabis Products Market
25. Middle East Cannabis Products Market
26. Africa Cannabis Products Market
27. Cannabis Products Market Competitive Landscape And Company Profiles
30. Appendix
Executive Summary
Major players in the cannabis products market are Canopy Growth Corporation, Aphria Inc, Aurora Cannabis, Cara Therapeutics, GW Pharmaceuticals PLC, Maricann Group, Tilray, The Cronos Group, Tikun Olam and United Cannabis Corporation.The global cannabis products market is expected to grow from $28.0 billion in 2021 to $35.0 billion in 2022 at a compound annual growth rate (CAGR) of 25.0%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $80.0 billion in 2026 at a CAGR of 23.0%.
The cannabis products market consists of sales of cannabis products and related services. Cannabis is a psychoactive drug which is obtained from the cannabis plant of the cannabaceae family. Cannabis can be used for the treatment of various diseases such as chronic pain, cancer pain, depression, anxiety disorders, sleep disturbances and neurological disorders.
The main types of products are flower, concentrates and others. The smokable section of the cannabis plant, also known as the bud or nug, is referred to as flower, bud, or nug. The different compounds include THC-dominant, CBD-dominant, balanced THC & CBD and can be used in medical, recreational. The various routes of administration include oral solutions and capsules, smoking, vaporizers, topicals and others.
North America was the largest region in the cannabis products market in 2021. Middle East is expected to be the largest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The growing applications of cannabis in the medical field is an important driver for the cannabis products market. Cannabis is a drug that comes from Indian hemp plants such as Cannabis sativa and Cannabis indica, with THC (delta-9 tetrahydrocannabinol) being the main active chemical in it. Cannabis has several medical applications in conditions such as nausea and vomiting, glaucoma, epilepsy, asthma. Hence, many countries have legalized the use of cannabis for medical applications despite it being a psychoactive drug. Medical applications of cannabis include treating cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, AIDS, Alzheimer's disease and Parkinson's disease. According to Harvard Health, around 85% of Americans supported legalizing medical marijuana, and at least several million Americans were using it.
The presence of several legal norms related to the use and possession of cannabis is an important restraint on the cannabis products market. These norms include regulations of the Food and Drug Administration (FDA) as well as rules set up by the government of each state in the USA. The FDA reviews all applications of cannabis products for their safety and effectiveness. Despite having laws allowing cannabis businesses, many states in the USA still do not allow such businesses. For instance, Los Angeles, San Francisco, San Jose and San Diego have laws allowing cannabis businesses, but 80% of California’s nearly 500 municipalities do not allow retail marijuana businesses.
Solar cannabis cultivation is an emerging trend in the cannabis products market. As cannabis cultivation requires a large amount of energy for lighting, heating, air-conditioning, and dehumidification systems, cannabis products manufacturing companies are investing in solar cannabis cultivation. This is mainly a result of legalizing cannabis products in various states of the USA, which is continuously increasing the consumption of energy and leading cannabis manufacturers to opt for solar cannabis cultivation. For instance, Aurora acquired 71 acres of land in Medicine Hat, Alberta, and installed a high-technology hybrid greenhouse cannabis production facility.
The government of California regulates the safety in manufacturing cannabis under the California Code of Regulations, Title 17 Division 1. It states that every manufacturer of cannabis product should obtain a valid license issued by state cannabis licensing agency. To obtain an annual license for cannabis manufacturing, the manufacturer should submit the physical address of the manufacturing premises and a written security plan. The security plan should include the security measures to prevent access of unauthorized people into the manufacturing premises and prevention of loss or theft of cannabis and cannabis products. Hence, this is expected to maintain vigil on manufacturing of cannabis in the coming the years.
In May 2020, Aurora Cannabis Inc., a Canada-based cannabinoids company acquired Reliva, LLC for an undisclosed amount. Through this acquisition Aurora and Reliva will be able to build a market-leading international cannabinoid platform, and they will be able to offer stable revenue and enhanced profitability. Reliva, LLC is a US-based company and a pacesetter in delivering high-quality hemp-derived CBD products to consumers.
The countries covered in the cannabis products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Canopy Growth Corporation
- Aphria inc.
- Aurora Cannabis
- Cara Therapeutics
- GW Pharmaceuticals plc.
- Maricann Group
- Tilray
- The Cronos Group
- Tikun Olam
- United Cannabis Corporation
- Medical Marijuana inc.
- MedReleaf Corporation
- Insys Therapeutics
- CanniMed Therapeutics
- Organigram Holdings
- ABcann Medicinals
- Lexaria Corp.
- Cannabis Sativa
- LivWell Enlightened Health LLC
- Scotts Miracle-Gro Co.
- Sprott inc.
- Cannabis Science inc.
- VIVO Cannabis
- STENOCARE
- Terra Tech Corp.
- MedMen
Methodology
LOADING...